Ipilimumab (anti-CTLA-4)
Ipilimumab (anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor. MW : 148 kD.
| Trivial name | MDX-010, BMS-734016 |
| Catalog Number | A2001 |
| CAS# | 477202-00-9 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/ipilimumab.html |
| Additional Information | https://file.selleck.cn/downloads/struct/Ipilimumab-chemical-structure-a2001.gif |